• novasure-controller.1513x854-1
  • 5
  • foto-co2-capsule.1708x964-1
  • device-arrayopen.1384x781.1384x781
  • novasure-device-meetsysteem.1500x847

NovaSure

Aktuelle Publikationen aus 2015 und 2016

Datum Publikationen Autors
1-8-2015 Economic and clinical benefits of radiofrequency ablation versus hysterectomy in patients suffering from menorrhagia: a retrospective analysis with German health claims data, Expert Rev. Med. Devices Early online Originalartikel in Englisch Sebastian Kessel, Juergen Hucke, Christoph Goergen, Ruediger Soeder, Thomas Roemer
2015 Hochfrequenzablation: Mehrwert auf den zweiten Blick, FRAUENARZT 56 (2015) Nr. 10 Rüdiger Söder, Daniel Böhm

Deutsche Studien

Datum Publikationen Autors
3/2010 ENDOMETRIUMABLATION - Operative, organerhaltende Behandlung der dysfunktionellen uterinen Blutung, FRAUENARZT Altgassen C, Bojahr B, Diedrich K, Gallinat A, Kreienberg R, Kreuz G, Römer T, Söder R, Wallwiener D
4/2013 Organerhalt dank transzervikaler Morcellation und Hochfrequenzablation, 04_2013_info@gynäkologie Fehr M
02/2009 Operative Behandlungsverfahren für dysfunktionelle uterine Blutungen, Ein Kosten-Nutzen-Vergleich, FRAUENARZT 2/2009 Gallinat A, Schmidt T
2004 NovaSure® Impedance-Controlled System for Endometrial Ablation: Three-year Follow-up on 107 Patients. Am J Obstet Gynecol 2004;191(5):1585-9. Gallinat A
2002 "NovaSure® Impedance-Controlled System for Endometrial Ablation. J Am Assoc Gynecol Laparoscop 2002;9(3):283-9." Gallinat A, Nugent W
2007 An Impedance-Controlled System for Endometrial Ablation: Five-Year Follow-up of 107 Patients. J Reprod Med 2007;5296):467-72 Gallinat A
3/2008 Operative Optionen bei Myomen und Adenomyosis uteri, gynäkologie + geburtshilfe 3/2008 Hucke J.
2/2014 Endometriumablation mittels Goldnetz, FRAUENARZT 2/2014 Klenske J.
10/2010 Hochfrequenzablation versus transzervikale Endometriumresektion, Prospektive klinische Vergleichsstudie zur Behandlung der rezidivierenden Hypermenorrhoe, FRAUENARZT 10/2010 Römer T, Socko P, Kreuz G

Internationale Studien

Datum Publikationen Autors
2003 AA double-blind randomized trial comparing the Cavaterm™ and the NovaSure® endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertil Steril 2003;80(1):203-8. Abbott J, Hawe J, Hunter D, Garry R
2003 Quality of life should be considered the primary outcome for measuring success of endometrial ablation. J Am Assoc Gynecol Laparosc 2003;10(4):491-5. Abbott J, Hawe J, Garry R
2011 Endometrial Cancer After Endometrial Ablation: Systematic Review of Medical Literature.Journal of Minimally Invasive Gynecology (2011) 18, 393–400 _ 2011 AAGL AlHilli, Mariam M., MB, BCh, Matthew R. Hopkins, MD, and Abimbola O. Famuyide, MBBS
2005 NovaSure Bipolar Radiofrequency Endometrial Ablation: Report of 200 Cases. J Obstet Gynaecol Can 2005;27(5):473-6. Baskett T, Clough H, Scott T
2005 "Bipolar radio frequency endometrial ablation compared with balloon endometrial ablation in dysfunctional uterine bleeding: impact on patients' health-related quality of life. Fertil Steril 2005;83(3):724-34." Bongers MY, Bourdrez P, Heintz AP, Brolmann HA, Mol BW.
2005 Randomized controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. Obstet Gynecol Surv 2005;60(2):93-4. Bongers M, Bourdrez P, Mol B, Heintz A, Brolmann H
2004 Randomized controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG 2004;111:1095–1102. Bongers M, Bourdrez P, Mol B, Heintz A, Brolmann H
2004 New endometrial ablation techniques for treatment of menorrhagia. Surg Technol Int 2004;12:161-70. Bradley L
2003 Endometrial ablation with NovaSure® GEA, a pilot study. Acta obstetricia et gynecologica Scandinavica. 2003;82(1):65-8. Busund B, Erno L, Gronmark A, Istre O
2004 Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices. J Reprod Med 2004;49(4):267-73. Cooper J, Gimpleson R
2002 A randomized, multicenter trial of safety and efficacy of the NovaSure® System in the treatment of menorrhagia. J Am Assoc Gynecol Laparoscop 2002;9(4):418-28. Cooper J, Gimpleson R, Laberge P, Galen D, Garza-Leal J, Scott J, Leyland N, Martyn P, Liu J
2001 NovaSure® GEA Technology Overview. Analysis of Worldwide Clinical Results. 2nd World Congress on Controversies in Obstetrics, Gynecology & Infertility; Paris, France; September 6-9, 2001. Cooper J
2001 Is endometrial pretreatment necessary in NovaSure 3-D endometrial ablation? Gynaecologic Endoscopy 2001 10(3):179-82. Cooper J, Brill A, Fulop T.
2012 International Heavy Menstrual Bleeding IPD Meta-analysis Collaborative Group: Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis. BMJ. 2012 Apr 23;344:e2564. doi: 10.1136/bmj.e2564. Daniels JP, Middleton LJ, Champaneria R, Khan KS, Cooper K, Mol BW, Bhattacharya S
2007 A survey of preferences and practices of endometrial ablation/resection for menorrhagia in the United Kingdom. Fertil Steril 2007; Dec 14 [Epub ahead of print]. Deb S, Flora K, Atiomo W.
2007 Essure sterilization associated with endometrial ablation. Int J Gynecol Obstet 2007; March 20 [Epub ahead of print]. Donnadieu AC, Deffieux X, Gervaise A, Faivre E, Frydman R, Fernandez H.
2007 Endometrial ablation devices: Review of a manufacturer and user facility device experience database. J Minim Invasive Gynecol 2007;14:436-41. Della Badia C, Nyirjesy P, Atogho A.
2007 for the Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) Research Group. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstet Gynecol. 2007;110(6):1279-1289. Dickersin K, Munro MG, Clark M, et al
2007 Global Endometrial Ablation for Menorrhagia in Women With Bleeding Disorders. Obstet and Gynecol 2007:109(6):1381-7. El-Nashar SA, Hopkins M, Feitoza SS, Pruthi RK, Barnes SA, Gebhart JB, Cliby WA, Famuyide AO
2009 Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol. 2009 Jan;113(1):97-106. El-Nashar SA, Hopkins MR, Creedon DJ, St Sauver JL, Weaver AL, McGree ME, Cliby WA, Famuyide AO
2005 Pathology of the NovaSure (radio-frequency) impedance-controlled endometrial ablation system. Arch Pathol Lab Med 2005;129(9):1175-8. Fadare O, Qin L, Martel M, tavassoli FA
2007 NovaSure impedance controlled endometrial ablation: Long-term follow-up results. J Minim Invasive Gynecol 2007;14(1):85-90. Fulop T, Rakoczi I, Barna I.
2001 NovaSure® Impedance Controlled Endometrial Ablation System. Long-term Follow-up Results. 2nd World Congress on Controversies in Obstetrics, Gynecology & Infertility; Paris, France; September 6-9, 2001. Fulop T, Rakoczi I, Barna I
2004 NovaSure® Impedance-Controlled System for Endometrial Ablation: Three-year Follow-up on 107 Patients. Am J Obstet Gynecol 2004;191(5):1585-9. Gallinat A
2002 NovaSure® Impedance-Controlled System for Endometrial Ablation. J Am Assoc Gynecol Laparoscop 2002;9(3):283-9. Gallinat A, Nugent W
2007 An Impedance-Controlled System for Endometrial Ablation: Five-Year Follow-up of 107 Patients. J Reprod Med 2007;5296):467-72 Gallinat A
2008 Patient Satisfaction After Radiofrequency Endometrial Ablation. Obstetrics and Gynecology 2008;111(4):79S. Glazerman L.
2007 Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. J Minim Invasive Gynecol 2007;14(4):494-501 Hopkins MR, Creedon DJ, El-Nashar SA, Brown DL, Good AE, Famuyide AO.
2008 Five-year follow up of a randomized controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG 2008;115(2):193-8 Kleijn JH, Engels R, Bourdrez P, Mol BWJ, Bongers MY.
2003 Assessment and Comparison of Intraoperative and Postoperative Pain Associated with NovaSure® and ThermaChoice Endometrial Ablation Systems. J Am Assoc Gynecol Laparoscop 2003;10(2):223-32. Laberge P, Sabbah R, Fortin C, Gallinat A
2001 Assessment and Comparison of Intraoperative and Postoperative Pain Associated with NovaSure® and ThermaChoice Endometrial Ablation Systems. J Am Assoc Gynecol Laparoscop 2003;10(2):223-32. Laberge P, Sabbah R, Fortin C, Gallinat A
Improved Premenstrual Syndrome Symptoms after NovaSure Endometrial Ablation. Lukes, Andrea S., MD*, Ryan J. McBride, PhD, Amy H. Herring, ScD, Michael Fried, MD, Atiya Sherwani, and Diana Dell, MD
2006 Endometrial ablation: where have we been? Where are we going? Clin Obstet Gynecol. 2006 Dec;49(4):736-66. Munro MG.
2006 Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study. J Minim Invasive Gynecol 2006;13(5):467-71. Sabbah R, Desaulniers G.
2006 Assessment of New Technology in the Treatment of Idiopathic Menorrhagia and Uterine Leiomyomata. Obstet and Gynecol 2006;108(4):990-1003. Sharp H.
2008 Global endometrial ablation devices. Clin Obstet Gynecol. 2008 Mar;51(1)::167-75 Sharp H.

Hormontherapie / Hormonfreisetzende Spirale

Datum Publikationen Autors
2000 Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. Br J Obstet Gynaecol. 2000;107(3):335-339. Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M.
2006 A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG. 2006;113(3):257-263. Busfield RA, Farquhar CM, Sowter MC, et al.
2001 Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. Br J Obstet Gynaecol. 2001;108(12):1222-28. Cooper KG, Jack SA, Parkin DE, Grant AM.
2000 Triphasic norgestimateethinyl estradiol for treating dysfunctional uterine bleeding. Obstet Gynecol. 2000;96(6):913-920. Davis A, Godwin A, Lippman J, Olson W, Kafrissen M.
2004 Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized 5-year follow-up. JAMA 2004;291(12):1456-63. Hurskainen R, Teperi J, Rissanen P, et al.

Relevante Produkte

aquilex

Aquilex Fluid Control System

Haben Sie Fragen? Rufen Sie uns an unter 0800 589 1635

Die Informationen auf dieser Website sind ausschließlich für medizinische Fachkreise bestimmt

Ja Ich gehöre zu diesem Fachkreis
Nein Ich gehöre nicht zu diesem Fachkreis